Acutus medical announces agreements to fund strategic growth priorities

Carlsbad, calif., april 27, 2022 (globe newswire) -- acutus medical, inc. (“acutus” or the “company”) (nasdaq: afib), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated, today announced a commitment letter from deerfield management company (“deerfield”), to refinance its existing debt with a new longer-term credit facility, and in conjunction with the refinancing, a definitive agreement to sell the company's left-heart access portfolio to medtronic. the combination of these two transactions, taken together with the company's recently completed restructuring, will result in a comprehensive recapitalization of the business to fund the company's strategic growth priorities.
AFIB Ratings Summary
AFIB Quant Ranking